Conference Chair and APAAACI President Prof. Ruby Pawankar talks about the highlights of this year's APAAACI Conference. Prof. Pawankar shares her thoughts about allergy prevention, the challenges of the global pandemic and the impact of her research on the next generation.
Subcutaneous and sublingual immunotherapy (SCIT, SLIT) are the most common methods for controlling allergic rhinitis (AR). At this year's APAAACI Congress, Prof. M. Okano, MD, presented research on the safety, efficacy and adherence of the two treatment regimens.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
We invite you to watch this symposium as a video on demand. This event was originally livestreamed during the first virtual APAAACI 2021 International Conference.
Since the first anaphylactic reactions after injection of the COVID-19 vaccines, studies on side effects and severe allergic events have been ongoing worldwide. Now there are also first results on a successful premedication scheme and vaccination concepts for high-risk patients.
Eight COVID-19 vaccines are licensed in the Philippines. Severe reactions to these and anaphylactic events occur very rarely. But to react early, an interdisciplinary team set up a concept for different risk groups.
The number of allergic reactions requiring treatment has risen sharply in recent years. Among triggering medications, antibiotics play a major role in daily practice. Yet, there is still a need for better documentation.
Food allergies are rising but it is still unclear why. This is also reflected in guidelines for the prevention and treatment of food allergies. Risk factors are being discussed again.
CRSwNP usually accompanies those affected throughout their lives. Multiple surgeries and long-term steroid therapy are the standard treatment. This can be extended by biologics use.
Prof Kari Nadeau, spoke at APAAACI 2021 on the state of oral immunotherapy for food allergies, possible triggers, useful biomarkers for prediction, and more.
From 15 to 17 October 2021, esanum will be reporting on the APAAACI 2021 International Conference for the first time as a digital media partner.
International experts from the fields of pneumology, allergology and immunology are expected at the APAAACI 2021 International Conference - for the first time in virtual form.